Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ATRC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 76.75%
March 31, 2026 76.87%
December 31, 2025 74.43%
September 30, 2025 74.90%
June 30, 2025 73.98%
March 31, 2025 74.31%
December 31, 2024 73.91%
September 30, 2024 74.22%
June 30, 2024 74.04%
March 31, 2024 73.98%
December 31, 2023 74.22%
September 30, 2023 74.40%
June 30, 2023 76.38%
March 31, 2023 74.45%
December 31, 2022 73.97%
September 30, 2022 74.13%
June 30, 2022 75.14%
March 31, 2022 74.55%
December 31, 2021 75.14%
September 30, 2021 74.12%
June 30, 2021 75.76%
March 31, 2021 75.14%
December 31, 2020 73.52%
September 30, 2020 73.66%
June 30, 2020 67.74%
Date Value
March 31, 2020 73.06%
December 31, 2019 73.02%
September 30, 2019 73.83%
June 30, 2019 74.51%
March 31, 2019 73.88%
December 31, 2018 72.96%
September 30, 2018 71.98%
June 30, 2018 73.51%
March 31, 2018 73.42%
December 31, 2017 70.95%
September 30, 2017 73.35%
June 30, 2017 71.97%
March 31, 2017 72.71%
December 31, 2016 70.21%
September 30, 2016 71.65%
June 30, 2016 72.64%
March 31, 2016 72.10%
December 31, 2015 71.23%
September 30, 2015 71.53%
June 30, 2015 70.95%
March 31, 2015 72.73%
December 31, 2014 69.42%
September 30, 2014 70.81%
June 30, 2014 70.83%
March 31, 2014 71.06%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 66.50%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
Baxter International, Inc. 33.55%